124
Participants
Start Date
April 1, 2019
Primary Completion Date
March 1, 2021
Study Completion Date
September 1, 2021
Transversus Abdominis Plane Block
Single-injection transversus abdominis plane block with 30 mL of 0.25% Bupivacaine with 1:400,000 epinephrine
Intravenous Lidocaine
Continuous intravenous lidocaine infusion
RECRUITING
Virginia Mason Medical Center, Seattle
Lead Sponsor
Benaroya Research Institute
OTHER